In vitro activity of rosamicin against Neisseria and Haemophilus, including penicillinase-producing strains.
Rosamicin was significantly more active against Haemophilus and Neisseria than are many antibiotics currently used to treat or prevent infection caused by these organisms. This enhanced activity was also observed against penicillinase-producing strains.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D006193:Haemophilus influenzae / Q000187:drug effects* / Q000201:enzymology; D008826:Microbial Sensitivity Tests; D009343:Neisseria / Q000187:drug effects* / Q000201:enzymology; D009344:Neisseria gonorrhoeae / Q000187:drug effects / Q000201:enzymology; D009345:Neisseria meningitidis / Q000187:drug effects / Q000201:enzymology; D010405:Penicillinase / Q000096:biosynthesis*
D000900:Anti-Bacterial Agents; D010405:Penicillinase